Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
Last modified: | 08 June 2017 1.25 p.m. |
More news
-
30 May 2024
Ben Feringa elected member American Philosophical Society
Prof. Ben Feringa has been elected member of the American Philosophical Society (APS)
-
29 May 2024
European joint Master’s degree programmes are among the top programmes
On 27 May, the EACEA in Brussels celebrated the fact that the first Erasmus Mundus Master’s degree programmes were launched twenty years ago.
-
28 May 2024
NWO Summit grant for research into molecular basis of life
RUG researchers partner in NWO Summit grant to research molecular basis of life.